Video

VIDEO: Patients with HIV, HCV face risk for re-infection following antiviral treatment

Hepatitis C virus re-infection is “an enormous issue” in patients with HIV who are treated, and cured, with direct-acting antivirals, according to Vincent Lo Re, MD, MSCE, of the University of Pennsylvania Perelman School of Medicine.

Lo Re reviews the incidence rate of re-infection, as well as the groups at highest risk and the uncertainty regarding whether insurance will pay for re-treatment of HCV. Counseling after treatment for HCV, particularly among patients who are cured, has the potential to “prevent [re-infection] from happening,” Lo Re said.

Research examining the risk factors for re-infection, which aims to help develop interventions to reduce the likelihood of its occurrence, is “going to be very important research for the future,” according to Lo Re.

Hepatitis C virus re-infection is “an enormous issue” in patients with HIV who are treated, and cured, with direct-acting antivirals, according to Vincent Lo Re, MD, MSCE, of the University of Pennsylvania Perelman School of Medicine.

Lo Re reviews the incidence rate of re-infection, as well as the groups at highest risk and the uncertainty regarding whether insurance will pay for re-treatment of HCV. Counseling after treatment for HCV, particularly among patients who are cured, has the potential to “prevent [re-infection] from happening,” Lo Re said.

Research examining the risk factors for re-infection, which aims to help develop interventions to reduce the likelihood of its occurrence, is “going to be very important research for the future,” according to Lo Re.